GUMINSKI, A.; FOLEY, P.; GROB, J.-J.; ROBERT, C.; GUTZMER, R. .; SQUITTIERI, N.; KIECKER, F. Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s181, 2023. DOI: 10.25251/skin.7.supp.181. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2013. Acesso em: 4 jul. 2024.